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ABSTRACT 
 
The thesis entitled “Total Synthesis of Bioactive Natural Products and Development 
of New Synthetic Methodologies along with Chemical Investigation on Novel 
Natural Anticancer Agents” has been divided into three chapters. 
CHAPTER I: Total Synthesis of Bioactive Natural Products 
 SECTION A: Stereoselective total synthesis of Xestodecalactone C. 
xestodecalactones C (1) is ten-membered ring keto lactone that bear a fused 1, 3-
dihydroxybenzene ring. Xestadecalactones C (1) were first isolated in 2002, from the 
fungus Penicillium cf. montanense, which in turn is found in the marine sponge 
Xestospongia exigua.67  
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The synthesis of xestodecalactone C (1) started with chiral propelene oxide which was 
opened with THP protected propargyl alchol yield the corresponding hydroxy ether 2 in 
80% yield, followed by protection with tert-butyl diphenyl silyl chloride in the presence 
of imidazole in dry DCM to afford the corresponding TPS protected homopropargylic 
alcohol 3, which was deprotected with PPTS in MeOH to afford the corresponding THP 
deprotected alcohol 4. Treatement of 4 with Red-Al gave the desired allyl alcohol 5 in 
80% yield. The allyl alcohol 5 was treated with (-)-DET, titanium(IV) isopropoxide and 
tert-butyl hydroperoxide in dichloromethane in anhydrous conditions to yield epoxy 
alcohol 6 in 82% yield which was opened by using highly selective reducing agent Red-
Al to afford the 1, 3-diol 7, which was subjected to selective primaryhydroxy 
etherification of primary hydroxyl with PMBBr and NaH in dry THF  to gave 8, which 
was further protected with benzyl bromide / NaH afforded benzyl ether 9. Then our 
required monohydroxy product 10 for esterification was achieved by deprotection of  
TPS group in presence of TBAF in THF. The alcohol 10 was esterified with 3, 5-
dimethoxyphenylacetic acid using DCC and DMAP73 to give the ester 11. The P- 
methoxy benzyl group in compound 11 was deprotected using DDQ in CH2Cl2–H2O to 
afford the primary alcohol 12. The primary alcohol in compound 12 was oxidized with 
Jones reagent (5 equiv) in acetone at 0 0C for 15 min to afford the acid 13. The desired 
macrolide 14 was obtained in 40% yield by intramolecular Friedel-Crafts acylation 
reaction of carboxylic acid 13 with a mixture of trifluoroacetic acid and trifluoroacetic 
acid anhydride at room temperature. The benzyl protection group in macrolide 14 was 
removed by hydrogenation using 5% palladium- on-carbon in ethyl acetate to furnish 
compound 15. Finally the methoxy groups in compound 15 using freshly prepared AlI3 at 
10 °C for 45 min to give the target molecule 1 in 96% yield. The structures of the 
products are determined from their spectral (IR, 1H, 13CNMR and MS data). 
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Scheme 1 
 
 
 
CHAPTER-II: Development of New Synthetic Methodologies 
This Chapter has been further divided into two sections  
SECTION-A: Chemical transformations by Diacetoxy iodobenzene o-Methylene  
 
1 An efficient bromination of alkenes and alkynes using potassium bromide and 
diacetoxy iodobenzene  
      Bromination of alkenes and alkynes into their corresponding bromo derivatives is 
highly useful in organic synthesis as the bromine group can be transformed to various 
other functional groups. The protection and deprotection of double bonds via 
bromination-debromination strategy can conveniently be utilized in synthetic 
routes.Brominated alkenes are also useful for the preparation of organometallic reagents. 
Bromination of alkenes and alkynes has efficiently been carried out at room temperature 
in short reaction times using KBr and diacetoxy iodobenzene in CH2Cl2-H2O (1:1) to 
prepare the corresponding trans-dibromo compounds in excellent yields as in Scheme 2. 
 
Scheme 2 
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The bromination of alkenes and alkynes (except phenyl acetylene) produced solely the 
trans vicinal dibromo compounds. Phenyl acetylene afforded the corresponding trans (E)- 
dibromo derivative as the major product (84%) along with the cis (Z)- dibromo 
compound in minor quantity (12%). The bromonium ion (Br+) generated in situ by the 
reaction of KBr and DIB reacts with the alkene or alkyne to form a cyclic bromonium ion 
intermediate which is attacked by bromide ion from the reverse side forming selectively 
the trans vicinal dibromo compound. From alkynes no tetrabromo derivatives were 
obtained. 
The structures of the products were determined from their spectral (IR, 1H, 13C NMR, 
Ms) data. 
2.  Hypervalent iodine-mediated efficient synthesis of imidazoles  
Imidazoles exhibit various interesting biological properties and many of them have been 
characterized as important therapeutic agents, fungicides and herbicides and plant growth 
regulators. They have also been applied in the synthesis of ionic liquids. 
Several heterocyclic compounds possessing imidazole skeleton have also been reported 
from natural source. Ravinder Reddy etal isolated 4-Butyl-2-chloro-5-formyl-1H-
imidazole 6, which have imidazole like skeleton from the stems of Jatropha curcas. 
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Because of such important biological activities and usefulness synthesis of triphenyl 
imidazoles is a great challenge to synthetic chemists. Here we report our work on the use 
of diacetoxy iodobenzene for the preparation of an imidazole derivative by treatment of 
an aldehyde with an α-hydroxy ketone and ammonium acetate as in Scheme 3 
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Scheme 3 
The present condensation mediated by DIB (Scheme 19) proceeded smoothly to afford 
the imidazoles in excellent yields (91-98 %). The conversion was complete within 30-60 
min. Both aromatic and aliphatic aldehydes were equally utilized for the preparation of 
imidazoles. Aromatic aldehydes containing electron-donating as well as electron-
withdrawing groups underwent the conversion facially. The probable mechanism of the 
conversion is shown in Scheme 4. 
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 Scheme 4 
The structures of the products were determined from their spectral (IR, 1H NMR and Ms) 
data. 
Section-B: 1. An efficient synthesis of benzyl bromides from aromatic aldehydes 
using polymethylhydrosiloxane and (bromodimethyl)sulfonium bromide or N- 
bromosuccinimide 
Synthesis of benzyl bromides from aromatic aldehydes in one pot synthesis is a great deal 
for Organic chemist. This reaction can be utilized in various organic transformations. 
Here we report our work on the use of Polymethylhydrosiloxane (PMHS) and 
(bromodimethyl)sulfonium bromide or NBS has been utilized here for the first time for 
an efficient synthesis of benzyl bromides from aromatic aldehydes at room temperature in 
excellent yields (Scheeme 5). 
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Scheme 5 
      A series of benzyl bromides were prepared from various aromatic aldehydes (Table 
2B).No disubstituted product was obtained. Aromatic aldehydes containing both electron-
donating and electron-withdrawing groups underwent the conversion smoothly. However, 
the aldehydes possessing electron-withdrawing groups required longer reaction times 
(Table2B, entries d and e) though the yields were very high. Alkyl, halogen, ether and 
nitro groups remained unaffected. Aliphatic aldehydes and ketones (both aliphatic and 
aromatic) did not show any change under the present reaction conditions. The 
combination of PMHS and Me2S+BrBr- was found to the better for reductive 
bromination of aromatic aldehydes compared to the combination of PMHS and NBS. For 
an example, the conversion of p-chlorobenzaldehyde into p-chlorobenzyl bromide (entry 
2) using the PMHS / Me2S+BrBr- required 4 h while PMHS / NBS 11 h. Both 
combinations converted the aromatic aldehydes into the corresponding benzyl bromides 
in similar yields. (Bromodimethyl)sulfonium bromide, an inexpensive reagent, has been 
used mainly as a catalyst but its reaction scope has not yet been fully explored.26 
The formation of benzyl bromides from aromatic aldehydes and PMHS/ Me2S+BrBr- 
may take place by reduction of the intermediate bromohydrin A or of the aldehyde into 
the corresponding alcohol derivative B followed by subsequent attack by bromide 
(Scheme 6).  
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The structures of the products were determined from their spectral (IR, 1H, 13CNMR and 
MS data). 
2. An efficient and facile hydro iodination of alkenes and alkynes using 
polymethylhydrosiloxane – iodine system 
Electrophilic addition of hydrogen halides to carbon−carbon double and triple bonds is 
one of the fundamental reactions in organic chemistry to synthesize alkyl and alkenyl 
iodides. Alkyl iodides are widely utilized as starting material in organic synthesis. 
Here we report our work on the use of Polymethylhydrosiloxane (PMHS) and Iodine 
system with olefins in chloroform at room temperature afforded the corresponding alkyl 
and alkenyl iodides in high yields, as depicted in (Scheme 7). 
 
 
 
 
 
 
Scheme 7 
The reaction carried out with substituted alkenes afforded a single regioisomer, showing 
addition of hydrogen iodide following Markovnikov’s35 rule. Accordingly, methyl 
acrylate and acrylonitrile yielded methyl-3-iodopropanoate and 3-iodopropane.The 
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structures of the products were settled from their spectral (IR, 1H NMR, and MS) and 
analytical data.  
Utility of polymethylhydrosiloxane (PMHS), a co-product of the silicone industry, as an 
inert reducing agent for environmentally benign procedures is well documented. 
However, to our knowledge; its use in combination with iodine for the synthesis of alkyl 
iodides has been explored here for the first time. 
 
The probable mechanism is shown in Scheme 24. Iodine reacts initially with PMHS to 
produce trimethylsilyliodide and the unstable agent A. This in situ is forming hydriodic 
acid, which is taking part in the reaction (Scheme 8). 
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Scheme 8 
Further, the alkynes were also treated with PMHS/I2 system to form the corresponding 
alkenyl iodides (Scheme 9. Reaction took comparatively longer duration (90 min) but 
again Markovnikov addition products were formed in high yields (Scheme 9. 
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Scheme 9 
The regio− and stereochemistry of the vinyl iodide 7n derived from the alkyne 6n (Table 
1). In 1H NMR of Product 7n (Table. 2B.2, Fig. 2B.1) showed the two olefinic protons 
resonated at δ 6.12 (1H, d, J = 2.0 Hz), 5.79 (1H, d, J = 2.0 Hz). The spectrum also 
showed signal at δ 4.20 (2H, m) indicating the presence of methelene protons attached to 
oxygen. The allylic protons resonated at 2.88 (1H, m), 2.70 (1H, m). It was also 
supported by the mass spectrum which given signal for EIMS: m/z 71 (M+.−I). 
Interestingly, in the case of cinnamyl alcohol, where an allylic alcohol system is present, 
the PMHS−I2 system afforded 1,3-diiodopropyl benzene (Scheme 26), showing addition 
of hydrogen iodide to the C−C double bond as well as substitution of the allylic hydroxy 
by iodine (Scheme 10). 
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This behaviour of the reagent system was found to be consistent with other allylic 
alcohols such as 3-methylbut-2-en-1-ol (Entry 16) and (E) hex-2-en-1-ol (Entry 17) 
leading to the formation of diiodo compounds.  
CHAPTER-III: Chemical investigation on Caesalpinia crista 
Plants and plants derived natural products have been in use to cure the human sufferings 
from time immemorial. The searching for pharmacologically active agents obtained by 
screening natural sources such as plant extracts has led to the discovery of many 
clinically useful drugs that play a major role in the treatment of human ailments. Today, 
plants continue to retain historical significance as important sources of novel compounds 
useful directly as medicinal agents or as lead compounds for synthetic or semi-synthetic 
structure modifications and optimization as biochemical or pharmacological probes. 
Caesalpinia is a genus of the family Leguminosae. The species belong to this 
genus are evergreen and deciduous trees, and shrubs grown as an ornamental plant. These 
are natives to tropical and subtropical countries, all over the world especially South 
America. The species are generally 15-20 meters in height and these plants have pretty 
flowers, and alternative, bipinnate leaves. The genus Caesalpinia contains about 100 
species showing a wide range of form. One of the important species of this genus is 
Caesalpinia pulcherrima. 
      
Various species of Caesalpinia are known for their medicinal properties. C. 
Pulcherrima is used in the form of decoction of the leaves, bark and roots to treat liver 
disorders and ulcers of the mouth and throat, reduce fever, cause abortions, and alleviate 
fungal infections.C. Crista is used as tonic for the treatment of rheumatism and back-
ache.3 C. Sappan is employed in traditional Chinese medicine as an emmengogue, 
haemostatic and anti-inflammatory agent. C. Major exhibits antihelmintic properties and 
is also applied to heat rheumatism and back-ache. C. decapetala is used by the tribal as 
folk medicine to treat neuralgia C. digyna exhibits significant diabetes properties. 
 
     The genus Caesalpinia which belongs to the family Leguminosae consists of 100 
species of which 9 species are found in India. A few plants of this genus are extensively 
used in traditional Indian Medicine in the treatment of tridosha, fever, ulcer, abortifacient, 
emmenagogue, asthma, tumors, vata and skin diseases.      
The metabolities obtained from different species of Caesalpinia are also 
chemically and biologically interesting. These metabolites are of varied types viz., 
diterpenoids, peltogynoids,homoisoflavonoids, flavonoids,amino acids and alkaloids. 
Chemical examination of the chloroform-methanol (1:1) extract of the plant afforded 
twelve compounds. The details of the extraction, isolation and structure elucidation of the 
compounds have been described. The investigation led to the isolation of two new 
diterpenoids along with ten known compounds, which are isolated first time from this 
species along with two known compounds already isolated from this species. The 
structures of new compounds were established from their elemental analysis and detailed 
spectroscopic (IR, 1D and 2D NMR and MS) data. The known compounds were 
identified from their physical and spectral data and by comparing the values with those 
reported in literature. 
The known compounds, 12-Demethyl neocaesalpin F are already reported to exhibit 
interesting anticancer properties. The new constituents has also presently been identified 
to possess significant cytotoxic activity.  
The following compounds are isolated from the plant Caesalpinia crista 
 
Entry Compound Remark 
A 6β, 7β-dibenzoyloxyvouacapen-
5α-ol 
 
New compound 
B 6β-cinnamoyloxy-7β-
acetoxyvouacapen-5α-ol 
 
New compound  
C Neo caesalpin G First report from the species 
D 12-Demethyl neocaesalpin F First report from the species 
E 5,7-dimethoxy-3’, 4’ 
methylenedioxy flavone 
First report from the species 
F Isobonducellin First report from the species 
G (E)-7-methoxy-3-(3′, 4′-
methylenedioxy benzylidene)-
First report from the species 
chroman-4-one 
H Bonducellin First report from the species 
I Sappanone Known compound 
J E-7-methoxy-3-(4′-methoxy 
benzylidene)chroman-4-one (7-
O-methyl bonducellin) 
Known compound 
K 5,7,4’-Trihydroxy- 6-methoxy 
flavonoid (hispidulin) 
First report from the species 
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 Anticancer activity of isolated 1-3 compounds 
Cytotoxic activity of compounds 1-3 on two different cancer cell lines 
 
 
 
     aThe results represent the mean ± standard error of four individual observations 
 
Compounds 1-3 were tested for in vitro cytotoxic activity against two cancer lines, HL-60 
(Human promyelocytic leukemia) and HeLa (Human cervical carcinoma) using the MTT 
assay according to the protocol of Mossmann.16 Camptothecin and etoposide were 
considered as the positive control. All the three compounds (1-3) showed significant 
decrease in cell viability in the test cell lines in a concentration dependent manner. IC50 
value was measured with each cell line after four individual observations (Table 2). The 
cytotoxic activity of the test compounds was found to be in the order of camptothecin> 
etoposide> 1> 2> 3 on both HL-60 and HeLa cells. 
 
 
 
 
 
     Sample                  IC50(µM)
a 
 HL-60 HeLa 
 Compound 1 17.37± 0.88 33.41± 0.75 
      Compound 2 19.77± 1.54 33.90± 0.66 
      Compound 3 44.89± 2.58 52.69± 2.48 
      Camptothecin 0.59 ± 0.04 0.94±0.07 
      Etoposide 1.81 ± 0.20 8.93±0.69 
